Go Backs
HomeCategoriesStatesCheck Your Home
Go Backs

Track product recalls and safety alerts from CPSC, FDA, NHTSA, and USDA. Stay informed and keep your family safe.

Browse

  • Categories
  • States
  • Check Your Home
  • Risk Levels

Agencies

  • CPSC
  • FDA Food
  • FDA Drug
  • FDA Device
  • FDA Veterinary
  • NHTSA
  • USDA

Company

  • About
  • FAQ
  • Contact
  • Terms of Service
  • Privacy Policy
Buy Me a Coffee

Recall data is sourced from official U.S. government agencies (CPSC, FDA, NHTSA, USDA) and processed using AI to improve readability. This site is not affiliated with or endorsed by any government agency. Always refer to the original agency notice for authoritative information.

ยฉ 2026 Go Backs. All rights reserved.

Medium RiskFDA Drug
Medications & Supplements/Prescription Drugs

SigmaPharm Laboratories LLC: Sodium Phenylbutyrate Powder Recalled for Failed Impurity Specifications

Agency Publication Date: September 30, 2021
Share:
Sign in to monitor this recall

Summary

SigmaPharm Laboratories LLC is recalling 1,192 bottles of Sodium Phenylbutyrate Powder (250 grams) because routine testing discovered impurity results that are outside of required safety specifications. This prescription medication is used to treat urea cycle disorders and is packaged in 500 cc white bottles with child-resistant caps. Consumers should check their medicine cabinet for the specific lot numbers and expiration dates affected by this nationwide recall.

Risk

The product contains impurities or degradation levels that exceed approved safety limits, which could potentially affect the medication's purity or effectiveness over time.

What You Should Do

  1. Check your Sodium Phenylbutyrate Powder (250 Grams) bottle for the following lot numbers: 2005401, 2005501, 2005601, or 2005701 with an expiration date of FEB 2023.
  2. Check for lot numbers 2101401 or 2101501 with an expiration date of FEB 2024.
  3. Verify the National Drug Code (NDC) on the label is 42794-086-14.
  4. If you have an affected bottle, contact your healthcare provider or pharmacist immediately for guidance on continued treatment and to obtain a replacement.
  5. Return any unused portions of the recalled medication to your pharmacy for a refund and contact SigmaPharm Laboratories LLC at 1-215-352-6655 for further instructions.
  6. For additional questions, contact the FDA Consumer Complaint hotline at 1-888-723-3332 (1-888-SAFEFDA) or visit www.fda.gov/safety/recalls.

Your Remedy Options

๐Ÿ’ฐFull Refund

Pharmacist consultation and refund

How to: Contact your healthcare provider or pharmacist for guidance. Return any unused product to the pharmacy for a refund

Affected Products

Product: Sodium Phenylbutyrate Powder (250 Grams)
Model:
NDC 42794-086-14
Recall #: D-0898-2021
Lot Numbers:
2005401 (Exp FEB 2023)
2005501 (Exp FEB 2023)
2005601 (Exp FEB 2023)
2005701 (Exp FEB 2023)
2101401 (Exp FEB 2024)
2101501 (Exp FEB 2024)
Date Ranges: Expiration February 2023, Expiration February 2024

Additional Information

Agency: Food and Drug Administration (FDA)
Event ID: 88736
Status: Resolved
Manufacturer: SigmaPharm Laboratories LLC
Sold By: pharmacies
Manufactured In: United States
Units Affected: 1192 bottles
Distributed To: Nationwide

Were You Affected by This Recall?

If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.

Find an Attorney

This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.

AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.

Sources: FDA iRES ยท Raw API Response

openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.